Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy

References

• Baek, S. K., Kim, S. Y., Lee, J. J., Kim, Y. W., Yoon, H. J., Cho, K. S. (2006) Increased ERCC Expression Correlates with Improved Outcome of Patients Treated with Cisplatin as an Adjuvant Therapy for Curatively Resected Gastric Cancer. Cancer Res Treat, 38, 19–24.
   PubMedGoogle Scholar
• Bouche, O., Ychou, M., Burtin, P., Bedenne, L., Ducreux, M., Lebreton, G., Baulieux, J., Nordlinger, B., Martin, C., Seitz, J. F., Tigaud, J. M., Echinard, E., Stremsdoerfer, N., Milan, C. & Rougier, P. (2005) Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol, 16, 1488–97.
   PubMed Web of Science ®Google Scholar
• Crew, K. D. & Neugut, A. I. (2006) Epidemiology of gastric cancer. World J Gastroenterol, 12, 354–62.
   PubMed Web of Science ®Google Scholar
• Goekkurt, E., Hoehn, S., Wolschke, C., Wittmer, C., Stueber, C., Hossfeld, D. K. & Stoehlmacher, J. (2006) Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)–novel predictors for response and survival in gastric cancer patients. Br J Cancer, 94, 281–6.
   PubMed Web of Science ®Google Scholar
• Goto, S., Iida, T., Cho, S., Oka, M., Kohno, S. & Kondo, T. (1999) Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res, 31, 549–58.
   PubMed Web of Science ®Google Scholar
• Harpole, D. H., Jr., Moore, M. B., Herndon, J. E., 2nd, Aloia, T., D’,amico, T. A., Sporn, T., Parr, A., Linoila, I. & Allegra, C. (2001) The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res, 7, 562–9.
   PubMed Web of Science ®Google Scholar
• Howie, A. F., Forrester, L. M., Glancey, M. J., Schlager, J. J., Powis, G., Beckett, G. J., Hayes, J. D. & Wolf, C. R. (1990) Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis, 11, 451–8.
   PubMed Web of Science ®Google Scholar
• Johnson, N. P., Hoeschele, J. D. & Rahn, R. O. (1980) Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA. Chem Biol Interact, 30, 151–69.
   PubMed Web of Science ®Google Scholar
• Kim, J. S., Kim, M. A., Kim, T. M., Lee, S. H., Kim, D. W., Im, S. A., Kim, T. Y., Kim, W. H., Yang, H. K., Heo, D. S., Bang, Y. J., Lee, K. U., Choe, K. J. & Kim, N. K. (2009) Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival. Br J Cancer, 100, 732–8.
   PubMedGoogle Scholar
• Kwon, H. C., Roh, M. S., Oh, S. Y., Kim, S. H., Kim, M. C., Kim, J. S. & Kim, H. J. (2007) Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol, 18, 504–9.
   PubMed Web of Science ®Google Scholar
• Lim, L., Michael, M., Mann, G. B. & Leong, T. (2005) Adjuvant therapy in gastric cancer. J Clin Oncol, 23, 6220–32.
   PubMedGoogle Scholar
• Marsh, S. & Mcleod, H. L. (2004) Cancer pharmacogenetics. Br J Cancer, 90, 8–11.
   PubMed Web of Science ®Google Scholar
• Matsubara, J., Nishina, T., Yamada, Y., Moriwaki, T., Shimoda, T., Kajiwara, T., Nakajima, T. E., Kato, K., Hamaguchi, T., Shimada, Y., Okayama, Y., Oka, T. & Shirao, K. (2008) Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer, 98, 832–9.
   PubMed Web of Science ®Google Scholar
• Metzger, R., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Lenz, H. J., Hayashi, K., Groshen, S., Salonga, D., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Konda, B. & Leichman, L. (1998) ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol, 16, 309–16.
   PubMed Web of Science ®Google Scholar
• Monden, N., Abe, S., Sutoh, I., Hishikawa, Y., Kinugasa, S. & Nagasue, N. (1997) Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology, 54, 391–9.
   PubMed Web of Science ®Google Scholar
• Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T., Wieand, H. S., O’brien, E. E., Poplack, D. G., Cossman, J., Myers, C. E. & Cowan, K. H. (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res, 49, 1422–8.
   PubMed Web of Science ®Google Scholar
• Ng, K., Meyerhardt, J. A. & Fuchs, C. S. (2007) Adjuvant and neoadjuvant approaches in gastric cancer. Cancer J, 13, 168–74.
   PubMedGoogle Scholar
• Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., Andre, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., Stahel, R., Sabatier, L., Pignon, J. P., Tursz, T., Le Chevalier, T. & Soria, J. C. (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med, 355, 983–91.
   PubMed Web of Science ®Google Scholar
• Park, D. J. & Lenz, H. J. (2006) Determinants of chemosensitivity in gastric cancer. Curr Opin Pharmacol, 6, 337–44.
   PubMed Web of Science ®Google Scholar
• Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J Clin, 55, 74–108.
   PubMed Web of Science ®Google Scholar
• Popat, S., Matakidou, A., Houlston, R. S. (2004) Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol, 22, 529–36.
   PubMed Web of Science ®Google Scholar
• Reed, E. (2005) ERCC1 and clinical resistance to platinum-based therapy. Clin Cancer Res, 11, 6100–2.
   PubMed Web of Science ®Google Scholar
• Sun, P., Xiang, J. B. & Chen, Z. Y. (2009) Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg, 96, 26–33.
   PubMedGoogle Scholar
• Tew, K. D. (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res, 54, 4313–20.
   PubMed Web of Science ®Google Scholar
• Tsuchida, S. & Sato, K. (1992) Glutathione transferases and cancer. Crit Rev Biochem Mol Biol, 27, 337–84.
   PubMed Web of Science ®Google Scholar
• Van Duin, M., De Wit, J., Odijk, H., Westerveld, A., Yasui, A., Koken, M. H., Hoeijmakers, J. H. & Bootsma, D. (1986) Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell, 44, 913–23.
   PubMed Web of Science ®Google Scholar
• Wagner, A. D., Grothe, W., Haerting, J., Kleber, G., Grothey, A. & Fleig, W. E. (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol, 24, 2903–9.
   PubMed Web of Science ®Google Scholar
• Wilson, M. D., Ruttan, C. C., Koop, B. F. & Glickman, B. W. (2001) ERCC1: a comparative genomic perspective. Environ Mol Mutagen, 38, 209–15.
   PubMed Web of Science ®Google Scholar
• Won, Y. J., Sung, J., Jung, K. W., Kong, H. J., Park, S., Shin, H. R., Park, E. C., Ahn, Y. O., Hwang, I. K., Lee, D. H., Choi, J. S., Kim, W. C., Lee, T. Y., Yoo, C. I., Bae, J. M., Kim, O. N., Chung, W., Kong, I. S. & Lee, J. S. (2009) Nationwide cancer incidence in Korea, 2003–2005. Cancer Res Treat, 41, 122–31.
   PubMedGoogle Scholar